1. Home
  2. CNO vs ADMA Comparison

CNO vs ADMA Comparison

Compare CNO & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNO Financial Group Inc.

CNO

CNO Financial Group Inc.

HOLD

Current Price

$42.80

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.15

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNO
ADMA
Founded
1979
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.1B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
CNO
ADMA
Price
$42.80
$19.15
Analyst Decision
Hold
Strong Buy
Analyst Count
5
2
Target Price
$43.60
$28.50
AVG Volume (30 Days)
651.0K
2.9M
Earning Date
11-03-2025
11-05-2025
Dividend Yield
1.65%
N/A
EPS Growth
20.08
205.35
EPS
2.98
0.86
Revenue
$4,441,500,000.00
$488,559,000.00
Revenue This Year
N/A
$22.19
Revenue Next Year
$3.57
$24.33
P/E Ratio
$13.84
$23.11
Revenue Growth
N/A
27.63
52 Week Low
$34.63
$13.50
52 Week High
$43.20
$25.67

Technical Indicators

Market Signals
Indicator
CNO
ADMA
Relative Strength Index (RSI) 67.78 58.36
Support Level $39.81 $19.13
Resistance Level $43.56 $20.46
Average True Range (ATR) 0.72 0.72
MACD 0.23 -0.08
Stochastic Oscillator 81.10 39.47

Price Performance

Historical Comparison
CNO
ADMA

About CNO CNO Financial Group Inc.

CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: